E-Health Lifestyle Intervention for Arthritis: A Pilot RCT on Feasibility
CHALAANE
Community Healthy Asian Lifestyle for Ameliorating Arthritis With Navigational E-health: A Pilot Randomized Controlled Trial on Feasibility and Acceptability
1 other identifier
interventional
50
1 country
2
Brief Summary
Knee osteoarthritis and obesity are common health problems in Hong Kong, especially among South Asian communities, where obesity rates are much higher than the general population. These two conditions often make each other worse-pain from arthritis leads to less physical activity, which can lead to more weight gain and more joint pain. This pilot study is testing a new digital health program called CHALAANE(Community health asian lifestyle for ameliorating arthritis with navigational e-health), which means "walk" in Hindi and Urdu. The program uses a smartband and a mobile app with artificial intelligence to help participants track their activity and diet. It also includes a 12-week supervised program with group walking sessions and lifestyle education. The study will include 50 South Asian adults aged 40 to 75 years who have knee osteoarthritis and obesity. Participants will be randomly assigned to one of two groups. The intervention group will receive the full CHALAANE program with an activated smartband and mobile app. The control group will receive an inactivated smartband for activity monitoring only. The study will last 10 months, with assessments at multiple time points. The main goal of this pilot study is to see if a larger future study would be feasible. The researchers will measure how many participants follow the program as instructed and how many complete the full 10-month study. They will also look at whether the program is acceptable to the South Asian community and gather early data on pain, physical function, and body composition. The study is a collaboration between the Department of Orthopaedics \& Traumatology at Queen Mary Hospital and The Duchess of Kent Children's Hospital. A total of 50 participants will be recruited. Results will help inform the design of a future full-scale trial to improve health outcomes in this underserved population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2026
CompletedFirst Posted
Study publicly available on registry
August 25, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
Study Completion
Last participant's last visit for all outcomes
May 31, 2029
August 25, 2026
August 1, 2026
2.3 years
August 17, 2026
August 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Adherence and follow-up rate
Adherence rate is defined as the proportion of participants following the study protocol: Using the smartband with Smartband+App and using Smartband+App on\> 70% of days are the predefined outcomes for adherence. Research Assistant/social worker will meet weekly with participants in both groups till study-end due to potential technological unfamiliarity of South Asians to troubleshoot usage problems, retrieve data simultaneously, and avoid misusing the smartband. This shall have the highest guarantee of adherence accuracy. Follow-up rate is defined is proportion of participants completing the study at 10 months (study end), with ≥ 70% as the predefined outcome. Achieving ≥ 70% for both rates is a predefined outcome that would enable scale-up to a larger project. Participants are free to drop out at any time point.
10 months (calculated at study end)
Intervention program and assessment acceptability
Acceptability was measured by the Client Satisfaction Questionnaire (CSQ) post-treatment as in similar OA programs (38). The CSQ is commonly used in treatment acceptability studies and includes items such as "How satisfied are you with the amount of help you received?" and "To what degree did the program teach you skills that are helping you to better manage your symptoms?" rated on a Likert scale. The assessment acceptability is also quantitatively assessed by a 5-point Likert questionnaire. ≥70% of participants rating the intervention and assessment as "acceptable" (i.e.,≥4/5 on the Likert scale) as the predefined threshold. Semi-structured interviews at study end will be conducted to capture feedback qualitatively
10 months (calculated at study end)
Recruitment rate
Ratio between the number of eligible participants recruited and the duration of recruitment period (per month). This will help estimate the recruitment time required for full trial.
12 months (throughout recruitment period)
Secondary Outcomes (19)
Performance-Based Functional Limitation Assessed by Gait Speed
Measurement at baseline, 1month 4 months, 7months and 10months
Self-Reported Functional Limitation Assessed by Western Ontario and McMaster Universities Osteoarthritis Index Physical Function Subscale
Baseline, 1 month, 4 months, 7 months, and 10 months
Pain Intensity Assessed by the Numerical Pain Rating Scale
Baseline, 1 month, 4 months, 7 months, and 10 months
Pain Assessed by the Western Ontario and McMaster Universities Osteoarthritis Index Pain Subscale
Baseline, 1 month, 4 months, 7 months, and 10 months
Stiffness Assessment Using the Western Ontario and McMaster Universities Osteoarthritis Index Stiffness Subscale
Baseline, 1 month, 4 months, 7 months, and 10 months
- +14 more secondary outcomes
Study Arms (2)
CHALAANE Program
EXPERIMENTALParticipants in this arm receive the full CHALAANE digital health intervention. They will use an activated smartband to monitor physical activity, a mobile application with artificial intelligence for dietary analysis and personalized feedback, and participate in a 12-week supervised practicum consisting of weekly group walking sessions and lifestyle education on healthy eating, pain management, and behavior change strategies. The intervention period is 10 months with assessments at baseline, 1, 4, 7, and 10 months.
Inactivated Smartband Only
ACTIVE COMPARATORParticipants in this arm receive an inactivated smartband for activity monitoring only. No feedback is provided, and participants do not receive access to the mobile application or the supervised practicum sessions. All other study procedures, including assessments and follow-up schedule, are identical to the intervention group. Assessments are conducted at baseline, 1, 4, 7, and 10 months.
Interventions
Participants in the control group receive an identical smartband that is inactivated, meaning it collects no activity data and provides no feedback to the participant. This serves as a minimal intervention to control for the effect of wearing a device while not receiving the active components of the CHALAANE program (AI dietary analysis, supervised practicum, and lifestyle education).
The CHALAANE intervention is a culturally tailored digital health program for South Asian adults with knee osteoarthritis and obesity. It consists of three integrated components: (1) an activated smartband that continuously tracks physical activity including step count, distance, and active minutes; (2) a mobile application with artificial intelligence for dietary logging and analysis, providing personalized feedback on calorie consumption and macronutrient composition; and (3) a 12-week supervised practicum with weekly group walking sessions and lifestyle education covering healthy eating, pain management, and behavior change strategies. The intervention period is 10 months.
Eligibility Criteria
You may qualify if:
- South Asian
- Men and women aged 40 to 75 years, with obesity (body mass index≥25 kg/m2, Hong Kong Centre for Health Protection obesity definition)
- Knee osteoarthritis (European League Against Rheumatism (EULAR) clinical criteria): age≥40 with movement-related joint pain, morning knee stiffness\<30 min, and functional limitations, and crepitus/reduced range/bony enlargement)
- Pain less than 2 years
You may not qualify if:
- Unwillingness/inability to change eating/physical activity habits
- Severe knee OA daily resting pain (NPRS\>8/10) or (Kellgren-Lawrence grade=4) that could not tolerate further conservative management
- inflammatory arthritis like rheumatoid arthritis, etc.
- Previous knee surgery
- immediate requirement for joint replacement, e.g. bone loss
- Planning to leave HK \>2 months during the study period
- cognitive impairment, vision and hearing impairment precluding use of Smartband+App
- losing/gaining \>5% weight in 6months or on dieting
- high levels of psychological distress (Kessler 10 questionnaire-K10 score \>29)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Queen Mary Hospital
Hong Kong, Pofuklam, 999077, Hong Kong
The Duchess of Kent Children's Hospital at Sandy Bay
Hong Kong, Sandy Bay, 999077, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcomes assessors are blinded to group allocation. The intervention delivery team cannot be blinded due to the nature of the supervised practicum sessions, as they facilitate the group walking and lifestyle education activities. The allocation sequence is concealed using sequentially numbered, opaque, sealed envelopes. Investigators responsible for data analysis will receive de-identified data with group codes that are not unblinded until the final analysis is completed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 17, 2026
First Posted
August 25, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
May 31, 2029
Last Updated
August 25, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers due to institutional data protection policies, patient confidentiality requirements, and the absence of a data sharing agreement in the study protocol. Access to study data will be restricted to the principal investigator and designated study team members for the purposes of data analysis and publication. All data will be stored in a password-protected computer and retained for 5 years after study completion, after which it will be destroyed in accordance with the protocol.